Georgios Manousakis, MD
Assistant Professor,
Contact Info
Assistant Professor
Neurologist
MD, University of Athens Medical School
Residency in Neurology, University of Wisconsin Hospital
Preliminary Residency in Internal Medicine, Maimonides Medical Center
Fellowship in Neuromuscular Medicine, Washington University
Summary
I have been Assistant Professor of Neurology at the University of Minnesota since 2012, and Director of the Neuromuscular Medicine Fellowship Program since 2017. My priorities include offering exceptional clinical care for patients with neuromuscular diseases, providing the most up-to-date neuromuscular education to students, residents, and fellows, and researching new therapeutic options for neuromuscular conditions that represent unmet medical needs, with a specific focus on myopathies of adults and ALS.
Expertise
Amyotrophic lateral sclerosis
Adult onset spinal muscular atrophy
Peripheral neuropathy
Neuromuscular junction disorders including myasthenia gravis
Muscular dystrophies of adults
Acquired myopathies of adults, including myositis
Awards & Recognition
AB Baker Teacher Recognition Award, American Academy of Neurology, 2019 William Kennedy Teaching Award, University of Minnesota Department of Neurology, 2014, 2018 Top Doctors, Rising Stars- Minneapolis & St Paul Magazine, 2015, 2016, 2017
Research
Research Funding Grants
04/2019-present
Greg Marzolf Jr Foundation
Serum uric acid as biomarker of type I myotonic dystrophy
Publications
1.Cheong I, Deelchand DK, Eberly LE, Marja?ska M, Manousakis G, Guliani G, Walk D, Öz G. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):294-301.
2.McClelland C, Manousakis G, Lee MS. Progressive External Ophthalmoplegia. Curr Neurol Neurosci Rep. 2016 Jun;16(6):53.
3.Miller TM, Pestronk A, David W, Rothstein J, Simpson E, Appel SH, Andres PL, Mahoney K, Allred P, Alexander K, Ostrow LW, Schoenfeld D, Macklin EA, Norris DA, Manousakis G, Crisp M, Smith R, Bennett CF, Bishop KM, Cudkowicz ME. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 2013 May;12(5):435-42.
4.Sattar A, Manousakis G, Jensen MB. Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther. 2010 Oct;8(10):1417-21.
5.Oczko-Walker M, Manousakis G, Wang S, Malter JS, Waclawik AJ. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency. J Clin Neuromuscul Dis. 2010 Dec;12(2):55-61
Clinical
Clinics
Neurology Clinic
Board Certifications
Neurology; Neuromuscular Medicine, Clinical Neuromuscular Pathology
Clinical Interests
ALS Peripheral neuropathy Neuromuscular junction disorders Muscular dystrophies of adults Acquired myopathies of adults